The Overlooked Factor: Iron Deficiency Anemia in Children with Obesity

Gül Trabzon1, Osman Fırat Çalışkan2, Servet Yüce3

  • 1Department of Pediatric Endocrinology, Hatay Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine, Hatay, Türkiye.

PubMed

Insights

Children with obesity have a higher risk of iron deficiency anemia (IDA) and related blood count abnormalities. Routine screening for IDA in pediatric obesity is recommended for early detection and intervention.

Area of Science:

  • Pediatric Hematology
  • Public Health Nutrition
  • Metabolic Disorders

Background:

  • Childhood obesity is a significant public health issue.
  • Obesity is linked to various metabolic and hematologic disturbances.
  • Iron deficiency anemia (IDA) is a common complication that may be overlooked in obese children.

Purpose of the Study:

  • To compare hematologic and biochemical profiles in children with obesity versus healthy controls.
  • To investigate the prevalence of anemia and related parameters in pediatric obesity.
  • To assess the association between obesity and iron deficiency anemia.

Main Methods:

  • Retrospective study comparing 84 children with obesity and 101 healthy controls.
  • Analysis of anthropometric and laboratory parameters including hemoglobin, MCV, RDW, serum iron, TIBC, ferritin, and vitamin B12.
  • Statistical comparison of hematologic and biochemical profiles between the two groups.

Main Results:

  • Children with obesity showed a higher frequency of anemia (22.6% vs. 10.9%) and microcytosis (53.6% vs. 32.7%).
  • Lower median serum iron levels (51 vs. 66 µg/dL) and higher TIBC (330 vs. 299 µg/dL) were observed in the obesity group.
  • Elevated ALT levels were noted in children with obesity (30 vs. 18 U/L).

Conclusions:

  • The prevalence of iron deficiency anemia and associated hematologic abnormalities is increased in children with obesity.
  • These findings underscore the importance of routine hematologic screening in pediatric obesity management.
  • Early detection and intervention are crucial for managing IDA in obese children.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.0K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169